沙门氏菌类型细胞分裂激活蛋白StCAP通过影响关键分子事件来影响病变发生
Kritika Singh1, Shubham Vashishtha1, Ankan Chakraborty1
1Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, New Delhi 110016, India.
ACS infectious diseases
|May 30, 2024
概括
耐多药型沙门氏菌的存活率取决于S. typhi细胞分裂激活蛋白 (StCAP). 用eltrombopag抑制StCAP提供了一种有前途的新治疗策略,用于对抗伤寒感染.
科学领域:
- 微生物学与传染病的研究
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 抗药多种类型的沙门氏菌为全球健康构成重大挑战.
- 识别保存的分子标对于开发新型抗伤寒疗法至关重要.
- S. typhi细胞分裂激活蛋白 (StCAP) 是一种在 S. typhi 变种中保存的蛋白质.
研究的目的:
- 调查StCAP作为一种潜在的治疗点对抗沙门氏菌.
- 描述StCAP的DNA结合特性,并确定潜在的抑制剂.
- 在体外和感染宿主细胞中评估StCAP抑制的疗效.
主要方法:
- 在和度分析中评估StCAP的DNA结合活性.
- 位点定向的突变发生,以确定关键的DNA相互作用残留物 (Arg34).
- 检测小分子 (eltrombopag,nilotinib) 进行StCAP抑制的查.
- 在S. typhi培养物和受感染的THP-1衍生巨细胞 (T1Mac) 上进行抑制测定.
- 拉下测试用于识别StCAP相互作用蛋白 (Apaf1).
- 在StCAP转移的T1Mac.Mac中分析了亡和自标志物 (caspase3,LC3II) 的分析.
主要成果:
- 证实StCAP是一种DNA结合蛋白,Arg34对DNA相互作用至关重要.
- 埃尔特朗博巴格显著结合StCAP的DNA结合口袋,并抑制了S. typhi的生长 (IC50 = 38μM).
- 埃尔特朗博巴格在感染的巨细胞中显示出更高的疗效 (IC50 = 10μM),阻碍了殖民地形成.
- StCAP与Apaf1相互作用,并影响宿主细胞亡和自途径.
- 通过StCAP转移的细胞显示LC3II增加和caspase3减少,表明StCAP促进宿主细胞存活.
结论:
- 在宿主感染期间,StCAP在Salmonella typhi的生存中发挥着至关重要的作用.
- 抑制StCAP,特别是用eltrombopag,是一个有前途的治疗策略.
- 准StCAP提供了一种新的方法来对抗多药耐药型伤寒.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K


